Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Graviti Pharmaceuticals Private Limited recalls Bupropion Hydrochloride Extended-Release Tablets USP (XL)

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed Tablet/Capsule Specifications
Products
  • Bupropion Hydrochloride Extended-Release Tablets USP (XL)
Where it was sold

Product was distributed to 1 distributor and 16 wholesalers/pharmacy retailers nationwide.

Nationwide

Units affected
46,512/30 count bottles
About this recall
Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist. by: Rising Phar, NDC 16571-863-03.